Zacutex lexipafant platelet activating factor (PAF) antagonist: Phase III Update

Based on work done in the U.K., the U.S. trial was begun in 1996 and designed to enroll 450 patients. Patients receive either

Read the full 235 word article

How to gain access

Continue reading with a
two-week free trial.